Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): Six-month echocardiographic follow-up

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1868-1872

  Hanna, Ibrahim R ^a   Kolm, Paul ^a   Martin, Randolph ^a   Reisman, Mark ^b   Gray, William ^b   Block, Peter C ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Swedish Cardiovascular Research   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

AF; atrial fibrillation; INR; international normalized ratio; LA; LAA; left atrial appendage; left atrium; left upper pulmonary vein; LUPV; mitral regurgitation; mitral valve; MR; MV; percutaneous left atrial appendage transcatheter occlusion; PLAATO; TEE

Indexed keywords

WARFARIN;

AGED; ARTIFICIAL EMBOLISM; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; DIASTOLE; DISEASE SEVERITY; EMBOLISM; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART LEFT ATRIUM; HUMAN; INSTRUMENTATION; MALE; MEASUREMENT; MITRAL VALVE REGURGITATION; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION; PRIORITY JOURNAL; PULMONARY VEIN; REVIEW; SYSTOLE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VEIN DIAMETER;

EID: 2442594034     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.050     Document Type: Article

References (13)

1. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 306:1982;1018-1022
2. Kopecky S.L., Grersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation. N Engl J Med. 317:1987;669-674
3. S.P.A.F. Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet. 343:1994;687-691
4. S.P.A.F. Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III Randomised Clinical Trial. Lancet. 348:1996;633-638
5. Hylek E.M., Skates S.J., Sheehan M.A., Singer D.E. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 335:1996;540-546
6. Ezekowitz M.D., Bridgers S.L., James K.E., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 327:1992;1406-1412
7. E.A.F.T. Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med. 333:1995;5-10
8. E.A.F.T. Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 342:1993;1255-1262
9. B.A.A.T.A.F. Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 323:1990;1505-1511
10. Stafford R.S., Singer D.E. Recent national patterns of warfarin use in atrial fibrillation. Circulation. 97:1998;1231-1233
11. Nakai T., Lesh M.D., Gerstenfeld E.P., Virmani R., Jones R., Lee R.J. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism. First experience in canine model. Circulation. 2217:2002;2217-2222
12. Sievert H., Lesh M.D., Trepels T., et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation. Circulation. 105:2002;1887-1889
13. Blackshear J.L., Odell J.A. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 61:1996;755-759